Glial cells are known to have a large impact on neuropathic pain conditions. Within the spinal cord, microglia rapidly respond to peripheral nerve injury, resulting in central sensitization and ultimately in the onset of enhanced pain behaviour. Astroglia respond with a short delay and are thought to contribute to the early maintenance of neuropathic pain. Nevertheless, it is unknown whether the roles of these glial cell types can be influenced by the chronicity of the neuropathology. Here, the persistent responses of astroglia and microglia to peripheral nerve injury within central pain networks in the upper dorsal horn laminae were studied. At 12 weeks after complete sciatic nerve injury, upregulation of glial fibrillary acidic protein (G...
Peripheral nerve injuries (PNIs) may result in cellular and molecular changes in supraspinal structu...
Microglial activation in the spinal cord plays a central role in the development and maintenance of ...
The differential pharmacological responsiveness of cephalic and extra-cephalic neuropathic pain has ...
Glial cells are known to have a large impact on neuropathic pain conditions. Within the spinal cord,...
Emerging research implicates the participation of spinal dorsal horn (SDH) neurons and astrocytes in...
The role of satellite glial cells (SGCs) of sensory ganglia in chronic pain begins to receive intere...
Neuropathic pain is caused by lesion or disease of somatosensory system. The glial cell includes ast...
Neuropathic pain is a common health problem that affects millions of people worldwide. Despite being...
The maladaptive response of the central nervous system (CNS) following nerve injury is primarily lin...
Management of chronic pain is a real challenge, and current treatments focusing on blocking neurotra...
Glial fibrillary acidic protein (GFAP) is a specific astrocytic marker in the central nervous system...
Abstract Neuropathic pain is generally defined as a chronic pain state resulting from peripheral and...
SummaryRecent studies suggest that astroglia, a major non-neuronal cell type in the central nervous ...
Reactive astrocytes and activated microglia are the key players in several pathophysiologic modifica...
International audienceBackground: Spinal reactive astrocytes and microglia are known to participate ...
Peripheral nerve injuries (PNIs) may result in cellular and molecular changes in supraspinal structu...
Microglial activation in the spinal cord plays a central role in the development and maintenance of ...
The differential pharmacological responsiveness of cephalic and extra-cephalic neuropathic pain has ...
Glial cells are known to have a large impact on neuropathic pain conditions. Within the spinal cord,...
Emerging research implicates the participation of spinal dorsal horn (SDH) neurons and astrocytes in...
The role of satellite glial cells (SGCs) of sensory ganglia in chronic pain begins to receive intere...
Neuropathic pain is caused by lesion or disease of somatosensory system. The glial cell includes ast...
Neuropathic pain is a common health problem that affects millions of people worldwide. Despite being...
The maladaptive response of the central nervous system (CNS) following nerve injury is primarily lin...
Management of chronic pain is a real challenge, and current treatments focusing on blocking neurotra...
Glial fibrillary acidic protein (GFAP) is a specific astrocytic marker in the central nervous system...
Abstract Neuropathic pain is generally defined as a chronic pain state resulting from peripheral and...
SummaryRecent studies suggest that astroglia, a major non-neuronal cell type in the central nervous ...
Reactive astrocytes and activated microglia are the key players in several pathophysiologic modifica...
International audienceBackground: Spinal reactive astrocytes and microglia are known to participate ...
Peripheral nerve injuries (PNIs) may result in cellular and molecular changes in supraspinal structu...
Microglial activation in the spinal cord plays a central role in the development and maintenance of ...
The differential pharmacological responsiveness of cephalic and extra-cephalic neuropathic pain has ...